Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1515740/000165495419013012/biei_10q.htm
June 2020
June 2020
May 2020
May 2020
May 2020
March 2020
October 2019
September 2019
August 2019
August 2019
Document and Entity Information - shares | 9 Months Ended | |
---|---|---|
Sep. 30, 2019 | Nov. 12, 2019 | |
Document And Entity Information | ||
Entity Registrant Name | PREMIER BIOMEDICAL INC | |
Entity Central Index Key | 0001515740 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2019 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Is Entity's Reporting Status Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Small Business | true | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 186,961,480 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2019 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1515740/000165495419013012/biei_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Premier Biomedical Inc.
Premier Biomedical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Premier Biomedical Inc provided additional information to their SEC Filing as exhibits
Ticker: BIEI
CIK: 1515740
Form Type: 10-Q Quarterly Report
Accession Number: 0001654954-19-013012
Submitted to the SEC: Thu Nov 14 2019 4:46:51 PM EST
Accepted by the SEC: Thu Nov 14 2019
Period: Monday, September 30, 2019
Industry: Biological Products No Disgnostic Substances